← boothcheck

CHE vs SHC stock comparison

CHEMED CORPORATION vs Sotera Health Co, two Medical Care stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.

Where CHE and SHC diverge most: on debt / equity, CHE reads 0.17 and SHC reads 3.46; on ev/ebitda, CHE reads 17.2 and SHC reads 276.8. The rest of the comparable metrics sit closer together. On valuation, today's CHE price has a different growth bar priced in than SHC (+5.9% implied for CHE vs +21.1% for SHC); the higher figure is the steeper assumption to clear, not a better or worse stock. What CHE's price implies is a bet that sits within the historical range (whole-company basis). What SHC's price implies is a bet that sits within the historical range (whole-company basis). The bull and bear cases for each are in their full reports below.

CHE vs SHC: the numbers

MetricCHESHC
Price$532.52$17.87
Market cap$7.0B$5.1B
SectorMedical CareMedical Care
StageMatureMature
Implied growth (priced in)+5.9%+21.1%
P/E26.843.6
P/B8.468.26
P/S2.714.32
EV/EBITDA17.2276.8
Revenue growth+3.4%+7.5%
Gross margin52.5%
Operating margin13.3%
Net margin10.6%9.9%
Return on equity33.1%18.9%
Return on assets17.4%3.6%
Return on invested capital26.7%
FCF yield4.4%1.9%
Dividend yield0.4%
Debt / equity0.173.46
Current ratio0.912.82
Altman Z (solvency)10.001.47
Piotroski F (quality)6 / 94 / 9
Full CHE report → Full SHC report →
Get boothcheck's read on CHE and SHC, and what their prices are betting on, in your inbox. No hype, no spam.
Free. Informational only, not investment advice. Unsubscribe anytime.

Compare any two stocks

vs

The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.